IJ Pharmaceutical Research
Lomustine Loaded Superparamagnetic Iron Oxide Nanoparticles Conjugated with Folic Acid for Treatment of Glioblastoma Multiforma (GBM)
Abstract
Acknowledgments
References
- 1.Brat DJ, Prayson RA, Ryken TC, Olson JJ. Diagnosis of malignant glioma: role of neuropathology. J. Neurooncol. 2008;89:287-311. [PubMed ID: 18712282].
- 2.Wen PY, Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008;359:492-507. [PubMed ID: 18669428].
- 3.Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-Oncol. 2014;16:iv1-iv63. [PubMed ID: 25304271].
- 4.Fang C, Wang K, Stephen ZR, Mu Q, Kievit FM, Chiu DT, Press OW, Zhang M. Temozolomide nanoparticles for targeted glioblastoma therapy. ACS Appl. Mater. Inter. 2015;7:6674-82.
- 5.Parsons DW, Jones S, Zhang X, Lin JCH, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807-12. [PubMed ID: 18772396].
- 6.Huse JT, Holland E, DeAngelis LM. Glioblastoma: molecular analysis and clinical implications. Annu. Rev. Med. 2013;64:59-70. [PubMed ID: 23043492].
- 7.Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310:1842-50. [PubMed ID: 24193082].
- 8.Mehrotra A, Nagarwal RC, Pandit JK. Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132. Chem. Pharm. Bull. 2011;59:315-20.
- 9.Mehrotra A, Pandit J. Critical process parameters evaluation of modified nanoprecipitation method on lomustine nanoparticles and cytostatic activity study on L132 human cancer cell line. J. Nanomed. Nanotechol. 2012;3:1-8.
- 10.Harvey KA, Xu Z, Saaddatzadeh MR, Wang H, Pollok K, Cohen-Gadol AA, Siddiqui RA. Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines. J. Neurosurg. 2015;122:547-56. [PubMed ID: 25526274].
- 11.Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303:1818-22. [PubMed ID: 15031496].
- 12.Davis ME, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug. Discov. 2008;7:771-82. [PubMed ID: 18758474].
- 13.Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 2009;86:215-23. [PubMed ID: 19186176].
- 14.Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 2003;36:R167.
- 15.Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 2008;29:487-96. [PubMed ID: 17964647].
- 16.Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H. EGFRvIII antibody–conjugated iron oxide nanoparticles for magnetic resonance imaging–guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res. 2010;70:6303-12. [PubMed ID: 20647323].
- 17.Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 2011;63:24-46. [PubMed ID: 20685224].
- 18.Garin-Chesa P, Campbell I, Saigo P, Lewis JrJ, Old L, Rettig W. Trophoblast and ovarian cancer antigen LK26 Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Clin. Pathol. 1993;142:557-67.
- 19.Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 2005;338:284-93. [PubMed ID: 15745749].
- 20.Reddy JA, Low PS. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit. Rev. Ther. Drug Carrier Syst. 1998;15:587-627. [PubMed ID: 9883391].
- 21.Zhang Y, Sun C, Kohler N, Zhang M. Self-assembled coatings on individual monodisperse magnetite nanoparticles for efficient intracellular uptake. Biomed. Microdevices. 2004;6:33-40. [PubMed ID: 15307442].
- 22.Veiseh O, Sun C, Gunn J, Kohler N, Gabikian P, Lee D, Bhattarai N, Ellenbogen R, Sze R, Hallahan A. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett. 2005;5:1003-8. [PubMed ID: 15943433].
- 23.Hu F, Neoh KG, Cen L, Kang ET. Cellular response to magnetic nanoparticles “PEGylated” via surface-initiated atom transfer radical polymerization. Biomacromolecules. 2006;7:809-16. [PubMed ID: 16529418].
- 24.Lutz JF, Stiller S, Hoth A, Kaufner L, Pison U, Cartier R. One-pot synthesis of PEGylated ultrasmall iron-oxide nanoparticles and their in-vivo evaluation as magnetic resonance imaging contrast agents. Biomacromolecules. 2006;7:3132-8. [PubMed ID: 17096542].
- 25.Ghasemi A, Jafari S, Salehi I. Synthesis and characterization of polyglycerol coated superparamagnetic iron oxide nanoparticles and cytotoxicity evaluation on normal human cell lines. Colloid. Surf. A Physicochem. Eng. Asp. 2018;551:128-36.
- 26.Jafari S, Cheki M, Tavakoli M, Zarrabi A, Sani KG, Afzalipour R. Investigation of combination effect between 6 MV X Ray radiation and polyglycerol coated superparamagnetic iron oxide nanoparticles on U87-MG Cancer Cells. J. Biomed. Phys. Eng. 2018;10:15-24.
- 27.Deng Y, Saucier-Sawyer JK, Hoimes CJ, Zhang J, Seo YE, Andrejecsk JW, Saltzman WM. The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles. Biomaterials. 2014;35:6595-602. [PubMed ID: 24816286].
- 28.Maity D, Choo SG, Yi J, Ding J, Xue JM. Synthesis of magnetite nanoparticles via a solvent-free thermal decomposition route. J. Magn. Magn. Mater. 2009;321:1256-9.
- 29.Zhao L, Chano T, Morikawa S, Saito Y, Shiino A, Shimizu S, Maeda T, Irie T, Aonuma S, Okabe H. Hyperbranched polyglycerol-grafted superparamagnetic iron oxide nanoparticles: synthesis, characterization, functionalization, size separation, magnetic properties, and biological applications. Adv. Funct. Mater. 2012;22:5107-17.
- 30.Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg. Med. Chem. 2009;17:2950-62. [PubMed ID: 19299149].
- 31.Lu AH, Salabas EeL, Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. Engl. 2007;46:1222-44. [PubMed ID: 17278160].
- 32.Tartaj P, Serna CJ. Synthesis of monodisperse superparamagnetic Fe/silica nanospherical composites. J. Am. Chem. Soc. 2003;125:15754-5. [PubMed ID: 14677960].
- 33.Huang FK, Chen WC, Lai SF, Liu CJ, Wang CL, Wang CH, Chen HH, Hua TE, Cheng YY, Wu M. Enhancement of irradiation effects on cancer cells by cross-linked dextran-coated iron oxide (CLIO) nanoparticles. Phys. Med. Biol. 2009;55:469-82. [PubMed ID: 20023329].
- 34.Marinin A. Synthesis and characterization of superparamagnetic iron oxide nanoparticles coated with silica [dissertation]. Royal Institute of Technology, Stockholm. 2012:1-50.
- 35.Keshavarzi E, Ghaeb Y, Rouhani S. The magnetic properties of Fe3O4 nanoparticale with different Coats and hydrodynamic diameters. 12th Iranian Seminar on Physical and Theoretical Chemistry; University of Kurdistan. 2010.
- 36.Wang L, Neoh K, Kang E, Shuter B, Wang SC. Superparamagnetic hyperbranched polyglycerol-grafted Fe3O4 nanoparticles as a novel magnetic resonance imaging contrast agent: an in-vitro assessment. Adv. Funct. Mater. 2009;19:2615-22.
- 37.Mohapatra S, Mallick S, Maiti T, Ghosh S, Pramanik P. Synthesis of highly stable folic acid conjugated magnetite nanoparticles for targeting cancer cells. Nanotechnology. 2007;18:385102.
- 38.Chen J, Li S, Shen Q, He H, Zhang Y. Enhanced cellular uptake of folic acid–conjugated PLGA–PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Drug Dev. Ind. Pharm. 2011;37:1339-46. [PubMed ID: 21524153].
- 39.Ankamwar B, Lai T, Huang J, Liu R, Hsiao M, Chen CH, Hwu Y. Biocompatibility of Fe3O4 nanoparticles evaluated by in-vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology. 2010;21:75102.
- 40.Choi JY, Lee SH, Na HB, An K, Hyeon T, Seo TS. In-vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines. Bioprocess. Biosyst. Eng. 2010;33:21-30. [PubMed ID: 19636592].
- 41.Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A. Assessing the in-vitro and in-vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem. Rev. 2011;112:2323-38. [PubMed ID: 22216932].
- 42.Sutradhar KB, Amin ML. Nanotechnology in cancer drug delivery and selective targeting. ISRN Nanomater. 2014;214:1-12.
- 43.Saatchi K, Gelder N, Gershkovich P, Sivak O, Wasan KM, Kainthan RK, Brooks DE, Häfeli UO. Long-circulating non-toxic blood pool imaging agent based on hyperbranched polyglycerols. Int. J. Pharm. 2012;422:418-27. [PubMed ID: 22044540].
- 44.Huang Y, Mao K, Zhang B, Zhao Y. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Mat. Sci. Eng. C-Mater. 2017;70:763-71.
Copyright
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Similar Articles
SPION Conjugated Curcumin Nano-Imaging Probe: Synthesis and Bio-Physical Evaluation
Rahimnia R, Salehi Z, Shafiee Ardestani M, Doosthoseini H. SPION Conjugated Curcumin Nano-Imaging Probe: Synthesis and Bio-Physical Evaluation. Iran J Pharm Res. 2019;18(1):e126159. doi: https://doi.org/10.22037/ijpr.2019.2331
Co -delivery of Sulforaphane and Curcumin with PEGylated Iron Oxide-Gold Core Shell Nanoparticles for Delivery to Breast Cancer Cell Line
Danafar H, Sharafi A, kheiri S, Kheiri Manjili H. Co -delivery of Sulforaphane and Curcumin with PEGylated Iron Oxide-Gold Core Shell Nanoparticles for Delivery to Breast Cancer Cell Line. Iran J Pharm Res. 2018;17(2):e124840. doi: https://doi.org/10.22037/ijpr.2018.2239
Preparation and Preliminary Evaluation of Dual-functional Nanoparticles for MRI and siRNA Delivery
Sun J, Zhou Y, Jin G, Jin Y, Quan J. Preparation and Preliminary Evaluation of Dual-functional Nanoparticles for MRI and siRNA Delivery. Iran J Pharm Res. 2021;20(4):e124269. doi: https://doi.org/10.22037/ijpr.2021.115099.15219
In-vitro Study of Multifunctional PLGA-SPION Nanoparticles Loaded with Gemcitabine as Radiosensitizer Used in Radiotherapy
Hamzian N, Hashemi M, Ghorbani M, Aledavood SA, Ramezani M, et al. In-vitro Study of Multifunctional PLGA-SPION Nanoparticles Loaded with Gemcitabine as Radiosensitizer Used in Radiotherapy. Iran J Pharm Res. 2019;18(4):e126268. doi: https://doi.org/10.22037/ijpr.2019.14050.12131
In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells
Ghadiri M, Vasheghani-Farahani E, Atyabi F, Kobarfard F, Hosseinkhani H. In-Vitro Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells. Iran J Pharm Res. 2017;16(4):e125070. doi: https://doi.org/10.22037/ijpr.2017.2133
Crossmark
Checking
- Scopus by DOI: 9
Last Update: 0 months ago
- Scopus by Title: 8
Last Update: 0 months ago
- Scopus by Title (Ref): 9
Last Update: 0 months ago
- CrossRef: 1
Last Update: 2 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):











